oleic acid has been researched along with celecoxib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| dos Santos Pyrrho, A; Kibwila, DM; Lara, MG; Leitão, A; Mata dos Santos, HA; Pádula, Md; Pierre, MB; Quiñones, OG; Rosas, EC | 1 |
| Borgheti-Cardoso, LN; Dante, MCL; Fantini, MCA; Lara, MG; Medina, WSG; Pierre, MBR; Praça, FSG | 1 |
| Chen, L; Deng, X; Hu, J; Li, X; Qiu, Z; Sheng, L; Zhang, C; Zheng, G; Zhou, J | 1 |
4 other study(ies) available for oleic acid and celecoxib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Celecoxib; Chemistry, Pharmaceutical; Edema; Glycerides; Male; Mice; Oleic Acid; Permeability; Propylene Glycol; Pyrazoles; Rabbits; Skin; Skin Absorption; Sulfonamides; Swine | 2014 |
Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Celecoxib; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Liberation; Edema; Glycerides; Inflammation; Liquid Crystals; Male; Oleic Acid; Permeability; Propylene Glycol; Rats; Rats, Wistar; Skin; Skin Absorption; Solubility; Water | 2018 |
Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Fatty Acid Synthase, Type I; Fatty Liver; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Oleic Acid; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |